Cancer Equity Colloquium 2024

THIS IS A HYBRID EVENT
 

Non Healthcare Professionals Registration Instructions:  Cancer Equity Colloquium 2024_registration instructions.pdf

Now more than ever, the presence of social inequities in healthcare is evident. This two-day, hybrid event, the Cancer Equity Colloquium, will address the diverse issues that underlie cancer inequities. The goal of the Colloquium is to bring together individuals from healthcare, academia, private/public business sector, and the public at large to develop unique approaches to tackling these inequities. We know that impactful initiatives to promote cancer equity require the skills and experiences of individuals from all these sectors of society. The speakers will reflect a similar mixture of backgrounds. Attendees will have the opportunity to engage with each other and the Cancer Equity Colloquium faculty to potentially develop novel partnerships.

Target audience

This activity is intended for Physicians, Nurses, Pharmacists, Psychologists, Physician Assistants, Social Workers, Other members of the healthcare team, General Public, and Patients & Caregivers.

Learning objectives

Upon completion of this activity, participants will be able to:

1. Recognize the determinants that drive cancer care inequity.
2. Formulate solutions to address factors leading to cancer inequity.
3. Develop collaborative initiatives to promote equity in cancer care.
4. Demonstrate the role of team science in the improvement of cancer inequities.

Promotional Supporters

For more information, please contact ebrooks3@mgb.org
 

Cancer Equity Colloquium 2024_Promotional Supporters.pdf

FUNDING

Cancer Equity Colloquium 2024 has received support in the form of an educational grant from the following companies: 
 
Astellas Pharma Global Development, Inc.
Bristol Myers Squibb
Merck Sharp & Dohme LLC
Sun Pharma

Registration instructions

Cancellation Policy:
Registrations cancelled on or before May 31, 2024 will be refunded, less a $20 administrative fee. Registrations cancelled after May 31, 2024 will not be refunded.

Contact partnerscpd@partners.org if you require assistance in cancelling your online registration.

ACCOMODATIONS/TRAVEL

A limited number of rooms have been blocked at the following nearby hotels for the nights of June 13, 14, and 15. Please see below for booking information.

Fairfield Inn Boston Medford
Click here to: Book your group rate at the Fairfield Inn Boston Medford
Room Rate: $249/night
Last Day to Book: Tuesday, May 14, 2024

AC Hotel Boston North
Click here to: Book your group rate for AC Hotel Boston North  
Room Rate: $269/night
Last Day to Book: Tuesday, May 14, 2024

Other hotels in the area:
Please note we do not have a room block for either of the following hotels:

The Row Hotel at Assembly Row
La Quinta Inn & Suites

TRANSPORTATION & PARKING

The meeting venue is accessible via the Assembly Row stop on the Orange Line and MBTA Route 90 Bus from Davis Square. Additionally, there are transportation resources available through Assembly Connect. Assembly Connect programs are free for residents, employees, and visitors to the Assembly Square District of Somerville, MA.

If you choose to drive and park at the MGB Assembly Row parking garage where the event is being held, the parking fees are as follows:

Additional information

Massachusetts General Hospital Cancer Center & Mass General Brigham 

Faculty credentials

COURSE CO-DIRECTORS

Colin D. Weekes, MD, PhD, FASCO
Christopher D. Horner Endowed Chair in Pancreatic Cancer,
Director, Pancreatic Cancer Research,
Director, Cancer Center Grand Rounds,
Director, Equity, Division of Hematology/Oncology,
Massachusetts General Hospital Cancer Center;
Associate Professor of Medicine, Harvard Medical School

Brenda Lormil-Raymond, MSN, FNP-C
Equity Nurse Practitioner, Phase I Research (Termeer Center), Massachusetts General Hospital Cancer Center;
Founder, Haitian American Medical Association (HAMA)

FACULTY

Brendan Abel, JD
Healthcare Policy & Advocacy Director, Johnson & Johnson;
Teaching Faculty, Harvard Medical School Center for Bioethics

Natasha Archer, MD
Physician, Dana Farber/Boston Children’s Cancer and Blood Disorders Center;
Assistant Professor of Pediatrics, Harvard Medical School

Sharl Azar, MD
Medical Director, Comprehensive Sickle Cell Disease Treatment Center,
Robert K. Kraft Chair in Diversity, Equity, and Inclusion,
Massachusetts General Hospital Cancer Center

Lourdes Baezconde-Garbanati, PhD, MPH
Associate Dean of Community Initiatives, KSOM
USC Distinguished Professor of Population and Public Health Sciences
Dept. of Population and Public Health Sciences
Associate Director of Community Outreach and Engagement, USC NCCC
Director, Center for Health Equity in the Americas (CenHealth)
Norris Comprehensive Cancer Center (USC NCCC)
Keck School of Medicine (KSOM)
University of Southern California (USC)

Aditya Bardia, MD, MPH, FASCO
Professor of Medicine, Geffen School of Medicine at UCLA,
Director, Breast Oncology Program,
Assistant Chief (Translational Research), Division of Medical Oncology,
Director of Translational Research Integration
UCLA Health Jonsson Comprehensive Cancer Center

Farrah A. Belizaire
Founder, LiteWork Events, LLC
Diversity Officer, MIT Brain & Cognitive Sciences

Regina Jeanise Brown, MD
Senior Medical Director, Clinical Research Physician
Early Development, Oncology
J&J Innovative Medicine
Johnson & Johnson

Taneshia Camillo-Sheffey
Consultant, Founder & Director,
The Haute House Design Studio
MadelNcubator, Inc

Duclas M. Charles, PharmD
Founder, Black Health Connect 

Chuck Christian
Cancer Thriver

Melissa B. Davis, PhD
Director, Institute of Translational Genomic Medicine (ITGM)
Professor, Department of Microbiology, Biochemistry, and Immunology
Morehouse School of Medicine
Georgia Research Alliance Distinguished Investigator

Pastor Cesar Depaz
Senior Pastor,
Hispanic Community Church of Boston

Yves M. Duroseau, MD, MPH
Chair, Emergency Medicine, Lenox Hill Hospital
President, Medical Board, Lenox Hill Hospital
Vice President, Western Region Emergency Medicine Service Line, Northwell Health

Fena Fenelon
CEO & Founder, Sofenomenal Agency Group,
Public Speaker,
Cancer Survivor (Colorectal) 

Marvella E. Ford, PhD
Professor and Vice Chair of Inclusive Excellence, Department of Public Health Sciences
Associate Director of Population Science and Community Outreach and Engagement,
Hollings Cancer Center
Medical University of South Carolina
SmartState Endowed Chair, Cancer Disparities Research, South Carolina State University

Wayne Frederick, MD, MBA
Charles  R. Drew Professor of Surgery,
Howard University

Jacquelyne Gaddy, MD, MSc, MSCR
Assistant Professor,
Deputy Director, Diversity Enhancement Program in Oncology,
Yale School of Medicine

Geoffrey A. Gallo
Head of State Government Affairs
AstraZeneca

James Hills
Java with Jimmy

Richard J. Lee, MD, PhD
Clinical Co-Director, The Claire and John Bertucci Center for Genitourinary Cancers
Assistant Physician, Department of Medicine
Massachusetts General Hospital Cancer Center

Lisa Lewis, MPH
Graduate Student,
Harvard Medical School, Center for Bioethics
Harvard Medical School, Department of Global Health and Social Medicine

Rev. Jean J.M. Louis
Senior Pastor, Free Pentecostal Church of God

Lady Katlyne D. Louis
Founder of Chosen Women of God & Rèspire Retreat & Restoration 

Kanisha Louis Jean, MSN, FNP-BC
Nurse Practitioner, Family Medicine, CCI Health Services
Mentor, Dotson Bridge & Mentorship Program, Simmons University;
Founder & President, MelanIN Medicine, Inc. 

Luckson Mathieu, MD
Senior Clinical Reviewer
FDA Division of Oncology 2

Olorunseun O. Ogunwobi, MD, PhD
Barnett Rosenberg Professor of Biochemistry and Molecular Biology,
Chairperson, Department of Biochemistry and Molecular Biology,
Michigan State University

Kenley Preval
MD/PhD Student, UMass Medical School;
Founder, Improving Academic Medicine Underrepresentation (IAMU)

Sana Raoof, MD, PhD
Resident Physician,
Memorial Sloan-Kettering Cancer Center

Kerry Reynolds, MD
Assistant Professor, Harvard Medical School;
Associate Physician, Massachusetts General Hospital Cancer Center
Clinical Director, Inpatient Oncology
Director, Severe Immunotherapy Complications Service

Natalie Sabga
Founder, The John E. Sabga Foundation

Veronica Sandoval, PhD, JD
Principal, Patient Inclusion & Health Equity
Chief Diversity Office,
Genentech, A Member of the Roche Group

Lecia Sequist, MD, MPH
Director, Cancer Early Detection and Diagnostics Program
Massachusetts General Hospital Cancer Center;
Landry Family Professor of Medicine, Harvard Medical School

Aithan Shapira, PhD, MFA
Founder, TILT;
Senior Lecture at Sloan School of Management, MIT

Cardinale Smith, MD, PhD
Chief Medical Officer, Tisch Cancer Hospital, The Mount Sinai Hospital
Vice President and Chief Quality Officer, Tisch Cancer Center, Mount Sinai Health System
Associate Director, Community Outreach and Engagement, Tisch Cancer Institute
Professor of Medicine, Division of Hematology/Medical Oncology and
Brookdale Department of Geriatrics and Palliative Medicine

Ryan Sullivan, MD
Associate Professor, Harvard Medical School;
Peter and Ann Lambertus Endowed Chair in Cancer,
Director, Center for Melanoma,
Massachusetts General Hospital Cancer Center

Erica Stringer-Reasor, MD
Associate Professor, Division of Hematology Oncology,
Vice Chair for Diversity, Equity, and Inclusion DOM,
Director, Breast Cancer Program,
O’Neal Comprehensive Cancer Center,
University of Alabama at Birmingham

J. Kevin Tucker, MD
Vice President, Education,
Mass General Brigham
Assistant Professor of Medicine, Harvard Medical School

Katia Vincent
Spoken Word Artist
Sickle Cell Thriver

Clayton C. Yates, PhD
John R. Lewis Professor of Pathology,
Professor of Pathology, Oncology, Urologic-Oncology,
Director for Translational Health Disparities and Global Health Equity Research,
Program Co-Leader for Cancer Genetics and Epigenetics,
Sidney Kimmel Comprehensive Cancer Center,
Johns Hopkins School of Medicine

Accreditation

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

AMA PRA Category 1 Credits^TM
Mass General Brigham designates this live activity for a maximum of 13.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing
Mass General Brigham designates this activity for 13.5 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.

Program

Friday, June 14, 2024 | 7:15am – 5:00pm

5:00 – 7:00pm – Welcome Reception
 

*The exhibit hall will be open during breakfast, breaks, and lunch

Saturday, June 15, 2024 | 8:30am – 4:00pm

*The exhibit hall will be open during breakfast, breaks, and lunch